(Reuters) – Moderna plans to submit an application to the U.S. health regulator for emergency use authorization (EUA) of its COVID-19 vaccine among kids between the ages of six months to five years by the end of the month, a company spokesperson said on Wednesday.
(Reporting by Amruta Khandekar and Sabahatjahan Contractor; Editing by Krishna Chandra Eluri)
